Answers are grounded in this paper and cite their sources.
The synthesis of new acylhydrazones based on derivatives of phosphorylacetic acids and 2,3-dihydroxybenzaldehyde was performed. Their antibacterial and cytotoxic activity was studied. Many of the prepared compounds surpass sorafenib in activity against M-HeLa cells. 2-Chloroethyl (E)-(4-diethylaminophenyl)-{2-[2-(2,3-dihydroxy-4,6-dicyclohexylbenzylidene)hydrazinyl]-2-oxoethyl}phosphinate showed selectivity towards tumor cells. The relationship between lipophilicity and antitumor effect was revealed. The results confirm the promise of the obtained acylhydrazones as potential selective antitumor agents.
No takes yet. Share an insight, caveat, or question.
Tagasheva et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: